Envestnet Asset Management’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $23.5M | Sell |
244,729
-29,667
| -11% | -$3.04M | 0.01% | 1330 |
|
|
2026
Q1 | $30M | Buy |
274,396
+21,054
| +8% | +$2.01M | 0.01% | 1082 |
|
|
2025
Q4 | $20.5M | Sell |
253,342
-37,331
| -13% | -$3.21M | 0.01% | 1191 |
|
|
2025
Q3 | $25.4M | Sell |
290,673
-13,883
| -5% | -$1.24M | 0.01% | 1129 |
|
|
2025
Q2 | $25.3M | Buy |
304,556
+19,447
| +7% | +$1.63M | 0.01% | 1106 |
|
|
2025
Q1 | $23.9M | Buy |
285,109
+25,680
| +10% | +$2.39M | 0.01% | 1087 |
|
|
2024
Q4 | $23.9M | Buy |
259,429
+16,886
| +7% | +$1.62M | 0.01% | 1093 |
|
|
2024
Q3 | $22.5M | Buy |
242,543
+26,702
| +12% | +$2.31M | 0.01% | 1101 |
|
|
2024
Q2 | $17.8M | Buy |
215,841
+1,520
| +0.7% | +$112K | 0.01% | 1203 |
|
|
2024
Q1 | $14.2M | Buy |
214,321
+10,568
| +5% | +$652K | 0.01% | 1306 |
|
|
2023
Q4 | $11.6M | Buy |
203,753
+7,770
| +4% | +$407K | ﹤0.01% | 1346 |
|
|
2023
Q3 | $10.7M | Buy |
195,983
+38,958
| +25% | +$2.31M | ﹤0.01% | 1325 |
|
|
2023
Q2 | $10.6M | Sell |
157,025
-19,556
| -11% | -$1.19M | ﹤0.01% | 1265 |
|
|
2023
Q1 | $9.09M | Sell |
176,581
-2,881
| -2% | -$140K | ﹤0.01% | 1290 |
|
|
2022
Q4 | $8.26M | Buy |
179,462
+4,809
| +3% | +$225K | ﹤0.01% | 1308 |
|
|
2022
Q3 | $8.85M | Buy |
174,653
+2,086
| +1% | +$104K | 0.01% | 1189 |
|
|
2022
Q2 | $7.86M | Buy |
172,567
+5,845
| +4% | +$261K | ﹤0.01% | 1279 |
|
|
2022
Q1 | $7.75M | Buy |
166,722
+6,100
| +4% | +$273K | ﹤0.01% | 1360 |
|
|
2021
Q4 | $8.07M | Buy |
160,622
+10,358
| +7% | +$536K | ﹤0.01% | 1311 |
|
|
2021
Q3 | $7.98M | Buy |
150,264
+9,641
| +7% | +$543K | ﹤0.01% | 1268 |
|
|
2021
Q2 | $8.58M | Buy |
140,623
+5,893
| +4% | +$313K | ﹤0.01% | 1224 |
|
|
2021
Q1 | $6.57M | Sell |
134,730
-2,334
| -2% | -$109K | ﹤0.01% | 1273 |
|
|
2020
Q4 | $5.55M | Buy |
137,064
+8,358
| +6% | +$299K | ﹤0.01% | 1231 |
|
|
2020
Q3 | $4.19M | Buy |
128,706
+15,838
| +14% | +$475K | ﹤0.01% | 1259 |
|
|
2020
Q2 | $2.98M | Buy |
112,868
+26,480
| +31% | +$692K | ﹤0.01% | 1373 |
|
|
2020
Q1 | $2.15M | Buy |
86,388
+12,311
| +17% | +$380K | ﹤0.01% | 1384 |
|
|
2019
Q4 | $2.66M | Buy |
74,077
+9,652
| +15% | +$333K | ﹤0.01% | 1454 |
|
|
2019
Q3 | $2.2M | Buy |
64,425
+15,647
| +32% | +$500K | ﹤0.01% | 1496 |
|
|
2019
Q2 | $1.36M | Buy |
48,778
+11,445
| +31% | +$318K | ﹤0.01% | 1765 |
|
|
2019
Q1 | $1.16M | Buy |
37,333
+16,005
| +75% | +$427K | ﹤0.01% | 1810 |
|
|
2018
Q4 | $504K | Buy |
+21,328
| New | +$583K | ﹤0.01% | 2154 |
|
|
2018
Q3 | – | Sell |
-6,121
| Closed | -$205K | – | 2010 |
|
|
2018
Q2 | $205K | Buy |
6,121
+698
| +13% | +$24.8K | ﹤0.01% | 1653 |
|
|
2018
Q1 | $196K | Buy |
5,423
+930
| +21% | +$32.2K | ﹤0.01% | 1596 |
|
|
2017
Q4 | $143K | Buy |
4,493
+1,117
| +33% | +$38.3K | ﹤0.01% | 1980 |
|
|
2017
Q3 | $126K | Buy |
3,376
+963
| +40% | +$32.8K | ﹤0.01% | 2002 |
|
|
2017
Q2 | $75K | Buy |
+2,413
| New | +$69.7K | ﹤0.01% | 2234 |
|
Other funds holding LMAT
CCA
CAM
CCM
Envestnet Asset Management's LMAT Position: Q2 2026 in Review
Envestnet Asset Management reduced its LeMaitre Vascular (LMAT) stake by 11% in Q2 2026, selling an estimated $3.04M and leaving 244,729 shares worth $23.5M. The position accounts for 0.01% of the portfolio, ranked #1330.
Envestnet Asset Management first reported a position in LMAT in Q2 2017 and has held it in 36 quarters since. The position peaked at $30M in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.
- Envestnet Asset Management held 244,729 shares of LeMaitre Vascular worth $23.5M as of Q2 2026.
- Envestnet Asset Management sold 29,667 LeMaitre Vascular shares in Q2 2026, an estimated $3.04M.
- LeMaitre Vascular made up 0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #1330 holding.
- Envestnet Asset Management first reported a position in LeMaitre Vascular in Q2 2017 and has held it in 36 quarters since.
- Envestnet Asset Management's LeMaitre Vascular position peaked at $30M in Q1 2026.
- 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.
Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.